Replies to post #52443 on US Stem Cell Inc (USRM)

[Havoc23]

To me it's relevant now, in that, RMAT takes in clinical evidence OUTSIDE of current trials as well. Yes, US Stem Cell may have limited patients in their "clinical trials", but they have a TON of data like this from South America, Europe, and Asia. I'm sure the FDA is also reviewing that data in addition to the phase 2/3 marvel data.

[stem cell cracka]

It popped up on my Google bioheart news alert with 4/14. Probably not new though